High HCV cure rates for people who use drugs treated with direct acting antiviral therapy at an urban primary care clinic
- 1 September 2017
- journal article
- research article
- Published by Elsevier in International Journal of Drug Policy
- Vol. 47, 196-201
Abstract
No abstract availableKeywords
Funding Information
- NIDA (K23DA039060)
- NIDA (K24DA036955)
- NIDA (R01 DA034086)
This publication has 28 references indexed in Scilit:
- Understanding real-world adherence in the directly acting antiviral era: A prospective evaluation of adherence among people with a history of drug use at a community-based program in Toronto, CanadaInternational Journal of Drug Policy, 2017
- Initial outcomes of integrated community-based hepatitis C treatment for people who inject drugs: Findings from the Queensland Injectors’ Health NetworkInternational Journal of Drug Policy, 2017
- Hepatitis C treatment as prevention: evidence, feasibility, and challengesThe Lancet Gastroenterology & Hepatology, 2016
- Can hepatitis C virus infection be eradicated in people who inject drugs?Antiviral Research, 2014
- Determinants of Hepatitis C Virus Treatment Completion and Efficacy in Drug Users Assessed by Meta-analysisClinical Infectious Diseases, 2012
- HIV/hepatitis C coinfection natural history and disease progressionCurrent Opinion in HIV and AIDS, 2011
- Global epidemiology of hepatitis B and hepatitis C in people who inject drugs: results of systematic reviewsThe Lancet, 2011
- Effectiveness of chronic hepatitis C treatment in drug users in routine clinical practice: results of a prospective cohort studyEuropean Journal of Gastroenterology & Hepatology, 2010
- Active intravenous drug use during chronic hepatitis C therapy does not reduce sustained virological response rates in adherent patientsJournal of Viral Hepatitis, 2008
- Hepatitis C Virus and Liver TransplantationClinics in Liver Disease, 2006